ClinicalTrials.govpublic full text
A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC
nsclc, neoadjuvant therapy, immunotherapy, ak112, bispecific antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840333
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.